Document is current
Any future updates will be listed below
-
Authors
Chavez Iglesias, Esther
Sucher, Anatol
Thati, Nidhi
Trudeau, Julia
Yom, Sue S.
Sirota, Marina
Olshen, Adam
Cho, Nam Woo
Kober, Kord M. https://orcid.org/0000-0001-9732-3321
-
Funding
Funding for this research was provided by:
National Institutes of Health (CA082103)
National Institutes of Health (CA233774)
- License Information
-
More Information
Article History
Received: 26 November 2025
Accepted: 29 July 2026
First Online: 31 August 2026
Declarations
Ethics approval and consent to participate: All procedures performed in studies involving human immune cells were in accordance with the ethical standards of the institutional and/or national research committee. These studies were reviewed and approved by the Institutional Review Boards. Alpha Independent Review Board (Alpha IRB) operates in compliance with applicable laws and regulations including, but not limited to, federal regulations at 45 CFR 46 and 21 CFR 50 and 56, that pertain to human subject protection, as well as other pertinent regulations and guidelines, such as the Good Clinical Practice (GCP) Guideline (E6) of the International Conference on Harmonization, as applicable. All patients/participants provided their written informed consent to participate in these studies.
Consent for publication: Not applicable.
Competing interests: The authors declare no competing interests.
